Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Weight Loss 2Stomach Neoplasms 2Malnutrition 2Esophageal Neoplasms 2Pituitary Neoplasms 1Periampullary Tumors 1Pancreatic Neuroendocrine Tumor G2 1Pancreatic Neoplasms 1Lymphocele 1Endocrine System Diseases 1Duodenal Neoplasms 1Breast Neoplasms 1Acromegaly 1

Interventions

Proton Therapy 2Propofol 2Hydrocortisone 2Desflurane 2parecoxib 1loxoprofen 1Yoga 1Transcranial Magnetic Stimulation 1Tramadol 1Surgical Procedures, Operative 1Supine Position 1Sevoflurane 1Saline Solution 1Rosiglitazone 1Resistance Training 1Radiation Dose Hypofractionation 1Protons 1Positron-Emission Tomography 1Octreotide 1Neurosurgical Procedures 1Neuropsychological Tests 1Nasal Lavage 1Human Growth Hormone 1Endoscopic Mucosal Resection 1Early Intervention, Educational 1Dexamethasone 1Deamino Arginine Vasopressin 1Cabergoline 1Bromocriptine 1Bed Rest 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Pituitary Neoplasms × Octreotide × Clear all
NCT01029275 2014-07-31

SAPORO

University Hospital, Rouen

Phase NA Completed
89 enrolled
Endocrine

Acromegaly, Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡